Cite
HARVARD Citation
Reinisch, W. et al. (2019). Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1. Inflammatory bowel diseases. 25 (4), pp. 803-810. [Online].